INSTRUCTIONS FOR AUTHORS
SUBSCRIBE
CALL FOR PAPERS
JOIN PEER REVIEW
PERMISSIONS REQUESTS
ABOUT US
CONTACT US
HOME
CURRENT ISSUE
PAST ISSUES
ONLINE ONLY
SUPPLEMENTS
CONTINUING EDUCATION
EDITORIAL BOARD
ANNUAL INDEX
ADA Highlights 2011
ADA
ADA President’s Views on Clinical Management of Type 2 Diabetes
Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs
Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin
Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes
Diabetes Prevention with Metformin Is Cost-Saving for Persons at High Risk
Linagliptin as Effective as Glimepiride with Improved Safety Profile
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Adding Saxagliptin to Metformin Improves Glycemic Control Over Uptitrating Metformin Dose
Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes
Treatment Satisfaction Highest for Diabetic Patients Taking Only Oral Medications
Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization
Ultra-Long-Acting Insulin Degludec Noninferior to Insulin Glargine with Less Hypoglycemia in Type 1 and Type 2 Diabetes
Education, Counseling Associated with Improved Clinical Outcomes in Type 2 Diabetes
HbA1c Screening Fails to Identify Many Patients with Diabetes and Prediabetes
Medical Food Improves Symptoms of Diabetic Neuropathy
Intensive versus Standard Blood Pressure Control of No Benefit in Quality of Life for Patients with Type 2 Diabetes
Artificial Pancreas Passes Test in Patients with Type 1 Diabetes
Concern Raised About Ocular Risks of Diabetes Treatments
Anti-VEGF Antibody Injections Improve Vision in Diabetic Macular Edema
Look AHEAD Trial: Intensive Lifestyle Intervention Can Achieve Sustained Weight Loss in Type 2 Diabetes
Perspective
ADA President’s Views on Clinical Management of Type 2 Diabetes
Diabetes Management
Education, Counseling Associated with Improved Clinical Outcomes in Type 2 Diabetes
HbA1c Screening Fails to Identify Many Patients with Diabetes and Prediabetes
Medical Food Improves Symptoms of Diabetic Neuropathy
Intensive versus Standard Blood Pressure Control of No Benefit in Quality of Life for Patients with Type 2 Diabetes
Artificial Pancreas Passes Test in Patients with Type 1 Diabetes
Concern Raised About Ocular Risks of Diabetes Treatments
Anti-VEGF Antibody Injections Improve Vision in Diabetic Macular Edema
Drug Therapy
Linagliptin as Effective as Glimepiride with Improved Safety Profile
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Adding Saxagliptin to Metformin Improves Glycemic Control Over Uptitrating Metformin Dose
Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes
Treatment Satisfaction Highest for Diabetic Patients Taking Only Oral Medications
Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization
Ultra-Long-Acting Insulin Degludec Noninferior to Insulin Glargine with Less Hypoglycemia in Type 1 and Type 2 Diabetes
Health Economics
Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs
Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin
Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes
Diabetes Prevention with Metformin Is Cost-Saving for Persons at High Risk
Weight Issues
Look AHEAD Trial: Intensive Lifestyle Intervention Can Achieve Sustained Weight Loss in Type 2 Diabetes
Search
Search this site:
e-Newsletter
E-mail Address
Close
Poll
Should everyone be required to purchase health insurance?:
Yes
No
